The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Luster, M. I.
Right arrow Articles by Rosenthal, G. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Luster, M. I.
Right arrow Articles by Rosenthal, G. J.

The Journal of Immunology, Vol 140, Issue 3 928-935, Copyright © 1988 by American Association of Immunologists

ARTICLES

Selective effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin and corticosteroid on in vitro lymphocyte maturation

MI Luster, DR Germolec, G Clark, G Wiegand and GJ Rosenthal
Immunotoxicology Group, National Institute of Environmental Health Sciences, Research Triangle Park, NC 27709.

The environmental contaminant 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and the corticosteroid dexamethasone have potent effects on lymphocyte function, although the effects of the former have not been well characterized. In the present studies murine B cell maturation was used as a model system to examine and compare the effects of TCDD and dexamethasone on cell function. Immunosuppression by TCDD and dexamethasone is mediated by binding to specific intracellular R referred to as the Ah and glucocorticoid R, respectively. Although both compounds were comparable in their ability to inhibit antibody responses to the T-independent antigen TNP-LPS, the events responsible for suppression were found to be distinct. Dexamethasone, although affecting multiple stages of B cell maturation, had its primary effect very early, manifested by inhibition of the phosphoinositide signal transduction pathway. This was evidenced by a decrease in accumulation of inositol phosphate and surface Ia antigen expression as well as an inability to enter the cell cycle after stimulation with anti-Ig. In contrast, neither early signaling events nor proliferation were affected in B cells treated with TCDD. However, TCDD inhibited Ig secretion after stimulation of B cells with T cell-replacing factor, suggesting that TCDD modulates the differentiation of B cells into plasma cells. These differential results were confirmed by monitoring the expression of surface antigens that occur on B cells, including Ia, 7D4, and PC.2, during this maturational process. Whereas dexamethasone inhibited the expression of surface antigens that occur early in maturation (Ia and 7D4), TCDD blocked only the expression of the plasma cell marker PC.2. Although TCDD altered later stages of the B cell cycle, the presence of TCDD was required at the time of initial activation to be effective, suggesting that TCDD may interfere with early cell programming.


This article has been cited by other articles:


Home page
 J. Pharmacol. Exp. Ther.Home page
D. Schneider, M. A. Manzan, R. B. Crawford, W. Chen, and N. E. Kaminski
2,3,7,8-Tetrachlorodibenzo-p-dioxin-Mediated Impairment of B Cell Differentiation Involves Dysregulation of Paired Box 5 (Pax5) Isoform, Pax5a
J. Pharmacol. Exp. Ther., August 1, 2008; 326(2): 463 - 474.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
C. E. W. Sulentic, W. Zhang, Y. J. Na, and N. E. Kaminski
2,3,7,8-Tetrachlorodibenzo-p-dioxin, an Exogenous Modulator of the 3'{alpha} Immunoglobulin Heavy Chain Enhancer in the CH12.LX Mouse Cell Line
J. Pharmacol. Exp. Ther., April 1, 2004; 309(1): 71 - 78.
[Abstract] [Full Text]

Home page
 Toxicol SciHome page
B. S. Yoo, D. R. Boverhof, D. Shnaider, R. B. Crawford, T. R. Zacharewski, and N. E. Kaminski
2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) Alters the Regulation of Pax5 in Lipopolysaccharide-Activated B Cells
Toxicol. Sci., February 1, 2004; 77(2): 272 - 279.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
R. B. Crawford, C. E. W. Sulentic, B. S. Yoo, and N. E. Kaminski
2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) Alters the Regulation and Posttranslational Modification of p27kip1 in Lipopolysaccharide-Activated B Cells
Toxicol. Sci., October 1, 2003; 75(2): 333 - 342.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
K. Inouye, T. Ito, H. Fujimaki, Y. Takahashi, T. Takemori, X. Pan, C. Tohyama, and K. Nohara
Suppressive Effects of 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) on the High-Affinity Antibody Response in C57BL/6 Mice
Toxicol. Sci., August 1, 2003; 74(2): 315 - 324.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
B. A. Vorderstrasse, E. A. Dearstyne, and N. I. Kerkvliet
Influence of 2,3,7,8-Tetrachlorodibenzo-p-dioxin on the Antigen-Presenting Activity of Dendritic Cells
Toxicol. Sci., March 1, 2003; 72(1): 103 - 112.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol Ind HealthHome page
Regulations and Advisories
Toxicology and Industrial Health, April 1, 2000; 16(3-5): 173 - 201.
[PDF]

Home page
 ScienceHome page
D. McConkey, P Hartzell, S. Duddy, H Hakansson, and S Orrenius
2,3,7,8-Tetrachlorodibenzo-p-dioxin kills immature thymocytes by Ca2+-mediated endonuclease activation
Science, October 14, 1988; 242(4876): 256 - 259.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1988 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1988 by The American Association of Immunologists, Inc. All rights reserved.